grant

The role of optic nerve lamina region stem cells in age-related optic nerve disease

Organization UNIVERSITY OF MARYLAND BALTIMORELocation BALTIMORE, UNITED STATESPosted 30 Sept 2022Deadline 30 Jun 2027
NIHUS FederalResearch GrantFY2025AccelerationAcuteAgeAgingAnteriorAnterior Ischemic Optic NeuropathyApoptosisApoptosis PathwayAstrocytesAstrocytusAstrogliaAxonBiologicalBlindnessBlood VesselsCell BodyCell Culture TechniquesCell DeathCell SurvivalCell ViabilityCell secretionCellsCellular SecretionCellular StressCellular Stress ResponseCessation of lifeCommon Rat StrainsCommunicationCouplingCranial Nerve IICranial Nerve II DiseasesCranial Nerve II DisorderDeathDefectDeoxypyrimidine KinaseDeoxythymidine KinaseDiseaseDisease ResistanceDisorderDissectionDissociationDistalEyeEyeballGanciclovirGancyclovirGeneralized GrowthGlaucomaGrowthGrowth AgentsGrowth FactorGrowth SubstancesHealthHumanIndividualIntraocular PressureIschemiaIschemic Optic NeuropathyMediatingMembraneMiceMice MammalsMicroRNAsModelingModern ManMolecularMurineMusNPCNatural regenerationNeural Stem CellNeural-Optical LesionNeurosphereNordeoxyguanosineNuclear Pore ComplexOcular TensionOptic DiskOptic NerveOptic Nerve DiseasesOptic Nerve HeadOptic Nerve IschemiaOptic NeuropathyOptic PapillaPOAGPatientsPhagocytesPhagocytic CellPhysiologic Intraocular PressurePredispositionPrevalencePrimary Open Angle GlaucomaProgenitor CellsProgrammed Cell DeathPropertyProteinsProteins Growth FactorsRatRats MammalsRattusRegenerationResistanceRetinaRetinal Ganglion CellsRodentRodent ModelRodentiaRodents MammalsRoleSecond Cranial NerveSecond Cranial Nerve DiseasesSightStressSupporting CellSusceptibilityTechniquesThinkingThymidine KinaseTissue GrowthTransgenic MiceTransgenic ModelVesicleVisionage associatedage correlatedage dependentage linkedage relatedage specificaged miceaged mouseagesaging processamebocyteastrocytic gliaaxonopathybiologicbiomarker arraybiomarker panelcell culturecell culturescell stressdeep sequencingeffective therapyeffective treatmentelderly miceenhancing factorexosomeextracellular vesiclesglaucomatousimprovedimproved outcomein vivoinjury recoveryinnovateinnovationinnovativeintra-ocular pressuremarker panelmembrane structuremiRNAmyelinationnano vesiclenanovesiclenecrocytosisnerve stem cellnestinnestin proteinneural precursorneural precursor cellneural progenitorneural progenitor cellsneural stem and progenitor cellsneurogenic progenitorsneurogenic stem cellneuron progenitorsneuronal progenitorneuronal progenitor cellsneuronal stem cellsneuroprogenitorneuroprotectionneuroprotectivenon-human primatenonhuman primateold miceontogenyoptic nerve disorderpostnatalprogenitor and neural stem cellsprogenitor cell markersprogenitor cell nicheprogenitor markersprogenitor nicheprogenitor stem cell markersrecovery after injuryrecovery following injuryrecovery post injuryregenerateresistance to diseaseresistantresistant diseaseresistant to diseaseretinal ganglionretinal stimulationsecond cranial nerve disordersocial rolestem and progenitor cell nichestem cell biomarkersstem cell markersstem cell nichestem cellsstress reductionthoughtstransgenic traitvascularvision lossvisual functionvisual loss
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

The most common age-associated optic nerve (ON)-related causes of vision loss are non-arteritic
anterior ischemic optic neuropathy (NAION) and primary open-angle glaucoma (POAG). Optic nerve head

(ONH) defects contribute to NAION and POAG susceptibility, but the mechanisms responsible for this are

incompletely understood, contributing to a lack of effective treatments. My lab recently discovered that the optic

nerve-laminar region (ONLR) within the ONH, contains a CNS neural stem cell/neural progenitor cell

(NSC/NPC) niche which is depleted during aging. Increased CNS-NPC activity has been shown to improve

baseline CNS activity in aged mice, and NPC depletion impedes CNS recovery following injury.

NPCs secrete extracellular vesicles (‘exosomes’) that mediate many of the positive effects of CNS-

NPCs. We find that administering human ONLR-NPC-secreted exosomes enhance RGC survival ex vivo and

stimulates RGC-neuritigenesis. Depleting ONLR-NPCs in a mouse transgenic model increases markers of

RGC stress, using an RGC stress-marker panel. I hypothesize that ONLR-NPCs support RGC survival, and

they do this in part by vesicle secretion. I predict their loss increases RGC stress and susceptibility to death

after axonal ischemic stress, and supplementing RGCs with ONLR-NPC-extracellular vesicles will enhance

RGC survival after axonal stress. We will prove this with two rodent species and two specific aims.

Specific aim 1: Demonstrate that mouse ONLR-NPC loss results in RGC stress and increases

RGC death in ON disease. We will couple a mouse transgenic model enabling selective ONLR-NPC

depletion, the rodent model of NAION rNAION model, and stereology (statistically robust cell quantification).

We will utilize molecular and cell biological techniques for identifying RGC cell stress and apoptosis. We will

then: A) Determine whether acute ONLR-NPC depletion results in RGC stress, via stress marker analysis and

B) Whether this depletion enhances RGC death after rNAION-induced RGC ischemic axonal stress. I predict

increased RGC stress, demonstrable by increased RGC-pJun expression and increased RGC loss.

Specific aim 2. Confirm that rat ONLR-NPC ‘exosomes’ protect RGCs in culture and in vivo during

ischemic ON stress. We will isolate rat ONLR-NPC secreted vesicles and confirm their ability to enhance

RGC survival, by: A) Administering rat ONLR-NPC vesicles and their dissociated components to cultured rat

RGCs, we will quantify their ability to enhance RGC survival and neuritigenesis. I predict improved RGC

survival and increased neuritigenesis. B) Using the rNAION model, we will intravitreally inject rat ONLR-NPC

derived exosomes and their components and determine whether these vesicles improve RGC survival and

reduce stress-related markers such as CRF and pJun. I predict reduced stress levels and improved long-term

RGC survival. Our innovative approach will identify the factors that contribute to RGC stress resistance and

generate new, improved approaches to treatment of optic nerve diseases.

Grant Number: 5R01EY032519-04
NIH Institute/Center: NIH

Principal Investigator: STEVEN BERNSTEIN

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →